Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
Dimensional National Municipal Bond ETF
DFNM
|
+$315M |
| 4 |
STL
Sterling Bancorp
STL
|
+$283M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$265M |
Sector Composition
| 1 | Financials | 16.89% |
| 2 | Technology | 16.18% |
| 3 | Industrials | 12.16% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
First US Bancshares
FUSB
$66.9M
| $346K | ﹤0.01% |
29,781
+313
| +1% | +$3.64K |
|
3227
Fulgent Genetics
FLGT
$683M
| $345K | ﹤0.01% |
5,527
| – | – |
|
|
TCRR
3228
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $342K | ﹤0.01% |
123,951
-2,585
| -2% | -$7.13K |
|
|
TOUR
3229
Tuniu
TOUR
$106M
| $340K | ﹤0.01% |
381,528
| – | – |
|
3230
StoneCo
STNE
$4.78B
| $339K | ﹤0.01% |
29,004
+3,647
| +14% | +$42.6K |
|
3231
Live Ventures
LIVE
$53.4M
| $336K | ﹤0.01% |
7,898
+1,476
| +23% | +$62.8K |
|
|
FFBW
3232
DELISTED
FFBW, Inc. Common Stock
FFBW
| $326K | ﹤0.01% |
27,016
| – | – |
|
3233
Pathfinder Bancorp
PBHC
$92.8M
| $324K | ﹤0.01% |
15,182
| – | – |
|
|
SRGA
3234
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $324K | ﹤0.01% |
35,463
-40,213
| -53% | -$367K |
|
3235
CKX Lands
CKX
$23.2M
| $322K | ﹤0.01% |
29,485
| – | – |
|
|
APTX
3236
DELISTED
Aptinyx Inc. Common Stock
APTX
| $320K | ﹤0.01% |
140,711
+16,774
| +14% | +$38.1K |
|
3237
Alpha Pro Tech
APT
$50.8M
| $319K | ﹤0.01% |
75,903
| – | – |
|
3238
GoodRx Holdings
GDRX
$1.43B
| $319K | ﹤0.01% |
+16,537
| New | +$319K |
|
3239
Bank7 Corp
BSVN
$460M
| $318K | ﹤0.01% |
13,445
+4,492
| +50% | +$106K |
|
|
ONEM
3240
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $316K | ﹤0.01% |
28,487
-4,269
| -13% | -$47.4K |
|
3241
J.W. Mays
MAYS
| $315K | ﹤0.01% |
8,193
| – | – |
|
3242
Socket Mobile
SCKT
$8.28M
| $310K | ﹤0.01% |
77,354
-2,118
| -3% | -$8.49K |
|
|
CBIO
3243
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $309K | ﹤0.01% |
2,711
-2,933
| -52% | -$334K |
|
3244
Veracyte
VCYT
$2.52B
| $309K | ﹤0.01% |
11,202
-175
| -2% | -$4.83K |
|
|
PFIN
3245
DELISTED
P&F Industries
PFIN
| $306K | ﹤0.01% |
50,884
+10
| +0% | +$60 |
|
3246
Hayward Holdings
HAYW
$3.39B
| $304K | ﹤0.01% |
+18,284
| New | +$304K |
|
3247
Driven Brands
DRVN
$3.04B
| $303K | ﹤0.01% |
+11,521
| New | +$303K |
|
3248
Carver Bancorp
CARV
$13.5M
| $302K | ﹤0.01% |
43,072
| – | – |
|
3249
Petco
WOOF
$1.02B
| $302K | ﹤0.01% |
15,432
+5,036
| +48% | +$98.6K |
|
3250
Foghorn Therapeutics
FHTX
$307M
| $300K | ﹤0.01% |
+19,758
| New | +$300K |
|